Skip to main content
Clinical Trials/RBR-7s8qnjj
RBR-7s8qnjj
Not yet recruiting
Phase 3

Effect of Botulinum Toxin Type A on neuromuscular plasticity in individuals with spasticity post-Stroke

niversidade Federal do Rio Grande do Sul -UFRGS0 sitesApril 27, 2022

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal do Rio Grande do Sul -UFRGS
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 27, 2022
End Date
September 30, 2022
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal do Rio Grande do Sul -UFRGS

Eligibility Criteria

Inclusion Criteria

  • individuals over 18 years of age; of both sexes; who have suffered a stroke; incident time greater than 12 months; ability to walk with or without crutches/canes; presence of spasticity in the ankle plantarflexor muscles

Exclusion Criteria

  • Individuals in rehabilitation or any treatment of a kinetic\-functional nature; individuals who have already applied botulinum toxin for less than six months; history of surgical procedure or use of orthopedic prosthesis; presence of neurological disease or dementia; cognitive alteration that prevents understanding of the research; presence of joint or musculoskeletal injury of an inflammatory nature

Outcomes

Primary Outcomes

Not specified

Similar Trials